Expression of integrin beta1 and its roles on adhesion between different cell cycle hepatocellular carcinoma cells (SMMC-7721) and human umbilical vein endothelial cells

To investigate expression of integrin β₁ and its roles on adhesion between different cell cycle hepatocellular carcinoma cell (HCC) and human umbilical vein endothelial cells (HUVEC), the synchronous G₁ and S phase HCC were achieved through thymine-2-deoxyriboside and colchicines sequential blockage method and double thymine-2-deoxyriboside blockage method, respectively. Expression of integrin β₁ on hepatocellular carcinoma cells was detected with flow cytometer. Further, the adhesive force of HCC to HUVEC and the role of integrin β₁ in this adhesive course were studied by micropipette aspiration technique. The results showed that percentage of each cyclic phases of the controlled HCC (non-synchronous) are: G₂+M phase, 11%; G₁ phase, 54%; S phase, 36%; the synchronous rates of G₁ and S phase HCC amount to 74 and 98%, respectively. The expressive fluorescent intensity of integrin β₁ in G₁ phase HCC is depressed significantly than the values of S phase and controlled HCC. Accordingly, the adhesive forces of G₁ phase HCC to HUVEC was significantly lower than the value of S phase cells (P<0.01), but it has no remarkable difference when compared the adhesive force values of S phase HCC with control; the contribution of integrin β₁ was about 50% in the adhesion of HCC to HUVEC. It suggested that HCC would be synchronized preferably in G₁ and S phase with thymine-2-deoxyriboside and colchicines, the adhesive molecule integrin β₁ expressed in a high lever in HCC and presented differences in vary cell cycle, and integrin β₁ played an important roles in adhesion of HCC to HUVEC. Possibly, S phase HCC take a great action in this adhesive course.